Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Non-Current Debt (2020 - 2025)

Historic Non-Current Debt for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $25.4 million.

  • MDxHealth's Non-Current Debt fell 3864.89% to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year decrease of 3864.89%. This contributed to the annual value of $41.4 million for FY2024, which is 3448.36% down from last year.
  • As of Q3 2025, MDxHealth's Non-Current Debt stood at $25.4 million, which was down 3864.89% from $24.5 billion recorded in Q2 2025.
  • MDxHealth's 5-year Non-Current Debt high stood at $24.5 billion for Q2 2025, and its period low was $1.5 million during Q4 2021.
  • Moreover, its 5-year median value for Non-Current Debt was $43.1 million (2022), whereas its average is $1.8 billion.
  • Within the past 5 years, the most significant YoY rise in MDxHealth's Non-Current Debt was 6080283.47% (2025), while the steepest drop was 3864.89% (2025).
  • MDxHealth's Non-Current Debt (Quarter) stood at $1.5 million in 2021, then surged by 3551.91% to $53.5 million in 2022, then increased by 18.16% to $63.3 million in 2023, then crashed by 34.48% to $41.4 million in 2024, then crashed by 38.62% to $25.4 million in 2025.
  • Its Non-Current Debt stands at $25.4 million for Q3 2025, versus $24.5 billion for Q2 2025 and $43.3 million for Q1 2025.